Literature DB >> 34496158

IRB Decision-Making about Minimal Risk Research with Pregnant Participants.

Amina White1, Christine Grady2, Margaret Little3, Kristen Sullivan4, Katie Clark5, Monalisa Ngwu6, Anne Drapkin Lyerly7.   

Abstract

Pregnant individuals are often excluded from research without clear justification, even when the research poses minimal risk of harm to the fetus. Little is known about institutional review board (IRB) decision-making practices when reviewing such research. We conducted a survey of current and former IRB personnel in the United States to elicit their interpretations of "minimal risk"-a formal regulatory category-and to identify factors that may influence IRB decisions to approve or disapprove research involving pregnant participants. Study results revealed some consensus among IRB members about the risk level of individual research procedures and hypothetical study vignettes. However, we uncovered important variations not only in the assessment of risk but also in the willingness of IRB members to approve minimal risk research that includes pregnant women. Based on our findings, guidance is needed to assist IRB members in characterizing risk, applying federal regulations, and appropriately ensuring the inclusion or justified exclusion of pregnant people in research.
© 2021 by The Hastings Center. All rights reserved.

Entities:  

Keywords:  IRB; clinical trials; human research ethics; institutional review board; minimal risk research; research with pregnant persons; research with pregnant women

Mesh:

Year:  2021        PMID: 34496158      PMCID: PMC9199078          DOI: 10.1002/eahr.500100

Source DB:  PubMed          Journal:  Ethics Hum Res        ISSN: 2578-2355


  16 in total

Review 1.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

2.  Inclusion of women in clinical trials--policies for population subgroups.

Authors:  J C Bennett
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

Review 3.  Accelerating the paradigm shift toward inclusion of pregnant women in drug research: Ethical and regulatory considerations.

Authors:  Amina White
Journal:  Semin Perinatol       Date:  2015-09-16       Impact factor: 3.300

4.  Enrolling pregnant women: issues in clinical research.

Authors:  Mary C Blehar; Catherine Spong; Christine Grady; Sara F Goldkind; Leyla Sahin; Janine A Clayton
Journal:  Womens Health Issues       Date:  2013-01

5.  Including Pregnant Women in Clinical Research: Practical Guidance for Institutional Review Boards.

Authors:  Pamela Payne
Journal:  Ethics Hum Res       Date:  2019-11

6.  The exclusion of pregnant, pregnable, and once-pregnable people (a.k.a. women) from biomedical research.

Authors:  V Merton
Journal:  Am J Law Med       Date:  1993

7.  The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women.

Authors:  Anna C Mastroianni; Robert Franceschini; Sarah L Wicks; Leslie Meltzer Henry
Journal:  Ethics Hum Res       Date:  2020-07

Review 8.  Exclusion of pregnant women from industry-sponsored clinical trials.

Authors:  Kristine E Shields; Anne Drapkin Lyerly
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

9.  Pregnant Women in Trials of Covid-19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials.

Authors:  Ruth Farrell; Marsha Michie; Rachel Pope
Journal:  Ethics Hum Res       Date:  2020-06-20

10.  Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Authors:  D Gonzalez; C Melloni; R Yogev; B B Poindexter; S R Mendley; P Delmore; J E Sullivan; J Autmizguine; A Lewandowski; B Harper; K M Watt; K C Lewis; E V Capparelli; D K Benjamin; M Cohen-Wolkowiez
Journal:  Clin Pharmacol Ther       Date:  2014-06-20       Impact factor: 6.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.